Schmeckpeper J, Kim K, George SA, Blackwell D, et al. RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease. J Mol Cell Cardiol 2023 Jun 5:S0022-2828(23)00101.
PMID: 37285929